High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study

Objectives: COVID-19 emerged and rapidly spread throughout the world. Testing strategies focussing on patients with COVID-19 require assays that are high-throughput, low-risk of infection, and with small sample volumes. Antigen surveillance can be used to identify exposure to pathogens and measure a...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Qiaoling, Ye, Guangming, Pan, Yunbao, Xie, Wen, Yang, Gui, Li, Zhiqiang, Li, Yirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317577/
https://www.ncbi.nlm.nih.gov/pubmed/34336884
http://dx.doi.org/10.3389/fmed.2021.676560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317577/
https://www.ncbi.nlm.nih.gov/pubmed/34336884
http://dx.doi.org/10.3389/fmed.2021.676560

Ejemplares similares